A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy

Condition:   Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Intervention:   Drug: Rituximab Sponsor:   Istituto Clinico Humanitas Active, not recruiting

Source: ClinicalTrials.gov - May 26, 2023 Category: Research Source Type: clinical trials